PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Primary Care, Geneva University Hospitals, Switzerland.\', \'Institute of Global Health, University of Geneva, Switzerland.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA.\', \'University Centre for General Medicine and Public Health (UNISANTE), University of Lausanne, Switzerland.\', \'Faculty of BioMedicine, Università della Svizzera Italiana, Switzerland.\', \'Department of Health and Community Medicine, University of Geneva, Switzerland.\', \'Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Switzerland.\', \'Division of Laboratory Medicine, Geneva University Hospitals, Switzerland.\', \'Department of Medicine, University of Geneva, Switzerland.\', \'Institute of Social and Preventive Medicine, University of Bern, Switzerland.\', \'Institute for Ethics, History, and the Humanities, University of Geneva, Switzerland.\', \'Geneva Center for Emerging Viral Diseases and Laboratory of Virology, Geneva University Hospitals, Switzerland.\', \'Department of Microbiology and Molecular Medicine, University of Geneva, Switzerland.\', \'Division of Infectious Diseases, Geneva University Hospitals, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/14034948211048050
?:hasPublicationType
?:journal
  • Scandinavian journal of public health
is ?:pmid of
?:pmid
?:pmid
  • 34664529
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.823
?:rankingScore_hIndex
  • 72
is ?:relation_isRelatedTo_publication of
?:title
  • Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all